Navigation Links
Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market
Date:8/17/2010

Oridion Signs New Distributor Agreement With IMI Expanding its Presence in... -- JERUSALEM and NEEDHAM, Massachusetts, August 18, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Contracts Click to view news release full screen  

Oridion Signs New Distributor Agreement With IMI Expanding its Presence in the Japanese Market

 

JERUSALEM and NEEDHAM, Massachusetts, August 18, 2010 /PRNewswire-FirstCall/ -- Oridion (SIX Swiss Exchange: ORIDN), creator of the Smart Capnography(TM) family of algorithm-based solutions (Integrated Pulmonary Index(TM), SARA(TM), and Smart Breath Detection Algorithm(TM)), announced the signing of a new agreement with IMI Co. Ltd., a leading distributor of medical equipment in Japan. This agreement provides Oridion with the opportunity to further expand into the Japanese market with its line of Microstream(R) capnography monitoring products.

IMI will bundle sales of Capnostream(R)20 Smart Capnography monitors including IPI* with their ventilators. This powerful combination will be offered as SafetySet(TM), an innovative solution to improve patient safety and make a clinical difference in patient care. IMI will begin selling the Capnostream(R)20 monitors and patented FilterLine(R) etCO2 sampling products immediately into the Critical Care environment and Home Care areas throughout Japan.

Mr. Kazumasa Tsumuga, President of IMI, said: "We are happy to join with Oridion to make available the best capnography technology to our hospital markets in Japan. We believe the collaboration between IMI and Oridion will help improve the safety for all the patient populations in all clinical settings in Japan."

Gerry Feldman, President of Oridion Capnography Inc., remarks, "We are honored to be working with IMI. The SafetySet package combining Capnostream capnography with ventilators sold by IMI is a pioneering strategy that will provide added safety for patients in hospitals throughout Japan. Oridion is committed to improving the standard of healthcare worldwide and will continue to offer new ways to improve patient safety and make a clinical difference in patient care."

*IPI helps caregivers manage complicated monitoring parameters with a single, simple number. The IPI utilizes real time measures and interactions of four parameters - exhaled carbon dioxide (etCO2), respiration rate, pulse rate, and oxygenation (SpO2) - to provide a single indexed value, enabling clinicians to instantly assess the patient's respiratory status.

SARA (Smart Alarm Respiratory Analysis) is an alarm management algorithm that, together with the Smart Breath Detection Algorithm, recognizes and reduces clinically insignificant alarms while accurately reflecting the patient's condition and preserving caregiver alarm vigilance.

About Oridion

Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States and Israel.

Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.

Certain statements made herein that are not historical are forward-looking. The words "estimate" "project" "intend" "expect" "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, among others, our ability to maintain profits, the market demands for our Capnography products, our ability to focus our team on the Capnography business, changes in general economic and business conditions, inability to maintain market acceptance to the Company's products, inability to timely develop and introduce new technologies, products and applications, rapid changes in the market for the Company's products, loss of market share and pressure on prices resulting from competition, introduction of competing products by other companies, inability to manage growth and expansion, loss of key OEM partners, inability to attract and retain qualified personnel, inability to protect the Company's proprietary technology. The Company does not assure any obligation to update the forward-looking information contained in this press release.

For further Oridion information please contact: Alan Adler, Chairman and Chief Executive Officer Walter Tabachnik, Chief Financial Officer Elena Gerberg, Investor Relations e-mail: info@oridion.com website: http://www.oridion.com phone: +972-2-589-9159 address: Oridion Systems Ltd., P.O. Box 45025, 91450 Jerusalem, Israel
'/>"/>

SOURCE Oridion Systems Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
2. Oridion Signs Agreement With Major US Health Plan Provider for Microstream(R) Capnography
3. Oridion Announces Significant Medical Research to be Presented at AARC Congress
4. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
5. BioNeutral Signs Agreement With a Non-profit for Long-Term Removal of Formaldehyde to Save 10,000 Mobile Homes in Louisiana
6. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
7. Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA)
8. Martek Signs Multi-Year Sole-Source Supply Agreement With Hero
9. NicOx Signs Agreement With Capsugel for the Commercial Manufacture of Naproxcinod Oral Capsules
10. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
11. Huifeng Bio-Pharmaceutical (HFGB) Signs Exclusive Management Operating Agreement with Xian Qinba Xintong Medical Ltd.; HFGB to Retain Up to 70% of Qinbas Total Profit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2017)... ... , ... Boston Strategic Partners, Inc. (BSP), a life-sciences and ... Research (HEOR) and ‘big data’ to provide in-depth analysis of pneumonia patients characteristics, ... trillion with nearly 1/3 spent on hospitalizations. BSP has access to real-world data ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... analytics solutions, today announced that its Anzo Smart Data Lake has been named ... includes technologies and solutions that help organizations succeed in surpassing their knowledge management ...
(Date:9/12/2017)... ... September 12, 2017 , ... Avomeen.com, ... product testing and development companies will be exhibiting at the 16th annual Contract ... Contract Pharma is an educational conference for pharma and bio-pharma professionals ...
(Date:9/12/2017)... ... September 12, 2017 , ... September ... announce that Jeremy Nicholson, Head of the Department of Surgery and Cancer and ... 2018 Wallace H. Coulter Lecture. His presentation, “Analytical Science in Precision Medicine: ...
Breaking Biology Technology:
(Date:4/6/2017)... 6, 2017 Forecasts by Product ... Readers, by End-Use (Transportation & Logistics, Government & Public ... & Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business ... Are you looking for a definitive report on ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
Breaking Biology News(10 mins):